Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gailani

Showing results (121-130 of 168) with videos related to

Pageof 17
Sort By:
Blood Advances|January 30, 2025
A model of zymogen factor XII: insights into protease activationAleksandr Shamanaev, Yujie Ma, Michal B Ponczek, et al.
Blood|December 29, 2018
A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chainIvan Ivanov, Anton Matafonov, Mao-Fu Sun, et al.
American Journal of Physiology. Cell Physiology|January 20, 2021
Role of platelets in regulating activated coagulation factor XI activityStéphanie E Reitsma, Jiaqing Pang, Vikram Raghunathan, et al.
Translational Stroke Research|May 2, 2013
Inhibition of Factor XII-Mediated Activation of Factor XI Provides Protection Against Experimental Acute Ischemic Stroke in MicePhilberta Y Leung, Sawan Hurst, Michelle A Berny-Lang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 27, 2019
Endothelial PAI-1 (Plasminogen Activator Inhibitor-1) Blocks the Intrinsic Pathway of Coagulation, Inducing the Clearance and Degradation of FXIa (Activated Factor XI)Cristina Puy, Anh T P Ngo, Jiaqing Pang, et al.
Research and Practice in Thrombosis and Haemostasis|March 25, 2025
Identification and characterization of factor XI autoantibodies in 2 patients with systemic lupus erythematosus: insights into mechanisms of acquired factor XI deficiencyPriyanka Srivastava, Amy Zhou, Christine Fuja, et al.
The New England Journal of Medicine|November 15, 2021
Milvexian for the Prevention of Venous ThromboembolismJeffrey I Weitz, John Strony, Walter Ageno, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2021
Kallikrein directly interacts with and activates Factor IX, resulting in thrombin generation and fibrin formation independent of Factor XIKatherine J Kearney, Juliet Butler, Olga M Posada, et al.
Frontiers in Pharmacology|January 5, 2024
Oral FXIIa inhibitor KV998086 suppresses FXIIa and single chain FXII mediated kallikrein kinin system activationAllen C Clermont, Nivetha Murugesan, Hannah J Edwards, et al.
Blood|November 22, 2023
A mechanism for hereditary angioedema caused by a methionine-379-to-lysine substitution in kininogensS Kent Dickeson, Sunil Kumar, Mao-Fu Sun, et al.
Pageof 17

Showing results (121-130 of 168) with videos related to

Sort By:
Pageof 17
Blood Advances|January 30, 2025
A model of zymogen factor XII: insights into protease activationAleksandr Shamanaev, Yujie Ma, Michal B Ponczek, et al.
Blood|December 29, 2018
A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chainIvan Ivanov, Anton Matafonov, Mao-Fu Sun, et al.
American Journal of Physiology. Cell Physiology|January 20, 2021
Role of platelets in regulating activated coagulation factor XI activityStéphanie E Reitsma, Jiaqing Pang, Vikram Raghunathan, et al.
Translational Stroke Research|May 2, 2013
Inhibition of Factor XII-Mediated Activation of Factor XI Provides Protection Against Experimental Acute Ischemic Stroke in MicePhilberta Y Leung, Sawan Hurst, Michelle A Berny-Lang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 27, 2019
Endothelial PAI-1 (Plasminogen Activator Inhibitor-1) Blocks the Intrinsic Pathway of Coagulation, Inducing the Clearance and Degradation of FXIa (Activated Factor XI)Cristina Puy, Anh T P Ngo, Jiaqing Pang, et al.
Research and Practice in Thrombosis and Haemostasis|March 25, 2025
Identification and characterization of factor XI autoantibodies in 2 patients with systemic lupus erythematosus: insights into mechanisms of acquired factor XI deficiencyPriyanka Srivastava, Amy Zhou, Christine Fuja, et al.
The New England Journal of Medicine|November 15, 2021
Milvexian for the Prevention of Venous ThromboembolismJeffrey I Weitz, John Strony, Walter Ageno, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2021
Kallikrein directly interacts with and activates Factor IX, resulting in thrombin generation and fibrin formation independent of Factor XIKatherine J Kearney, Juliet Butler, Olga M Posada, et al.
Frontiers in Pharmacology|January 5, 2024
Oral FXIIa inhibitor KV998086 suppresses FXIIa and single chain FXII mediated kallikrein kinin system activationAllen C Clermont, Nivetha Murugesan, Hannah J Edwards, et al.
Blood|November 22, 2023
A mechanism for hereditary angioedema caused by a methionine-379-to-lysine substitution in kininogensS Kent Dickeson, Sunil Kumar, Mao-Fu Sun, et al.
Pageof 17